TAVR-PRO

1 paper2 findings

Humans1

Associations

2

Mortality

upin humans1

1 study

TAVR-PRO is associated with mortality in humans.
Humansin elderly patients after TAVRn = 204
Development and Validation of a Predictive Risk Score for Poor Functional Outcome After Transcatheter Aortic Valve Replacement in Elderly Patients
Clinical interventions in aging13 Aug 2026

Poor 6-month functional outcomes

upin humans1

1 study

TAVR-PRO predicts poor 6-month functional outcomes in humans (AUC = 0.86).
Humansin elderly patients after TAVRn = 204
Development and Validation of a Predictive Risk Score for Poor Functional Outcome After Transcatheter Aortic Valve Replacement in Elderly Patients
Clinical interventions in aging13 Aug 2026

Latest

1 in 12 months

Clinical Interventions in Aging26 Aug

Development and Validation of a Predictive Risk Score for Poor Functional Outcome After Transcatheter Aortic Valve Replacement in Elderly Patients

Cohort study of 204 peopleBiomarkers